Oxytrol for Women

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0023-9637
  • Package NDC 0023-9637-04
  • Package NDC 0023-9637-08
  • Application number NDA202211
  • SPL ID cc404430-2345-4294-8efc-e1e996cc17b2
  • SPL set ID 8cdc5b4d-ff8d-4010-97d7-313422a0b868
  • UNII K9P6MC7092
  • RxCUI 403799
  • RxCUI 404448

What the source publishes

Labeler
Allergan, Inc.
Active ingredients
Oxybutynin
Form
PATCH
Routes
TRANSDERMAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN OTC DRUG
Prescription
Non-prescription

Names this record is found by

Complete source data
us:fda:ndc:0023-9637_cc404430-2345-4294-8efc-e1e996cc17b2
{
  "name": "Oxytrol for Women",
  "splId": "cc404430-2345-4294-8efc-e1e996cc17b2",
  "labels": [
    {
      "setId": "8cdc5b4d-ff8d-4010-97d7-313422a0b868",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8cdc5b4d-ff8d-4010-97d7-313422a0b868",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8cdc5b4d-ff8d-4010-97d7-313422a0b868"
    }
  ],
  "routes": [
    "TRANSDERMAL"
  ],
  "labeler": "Allergan, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "16 PATCH in 1 CARTON (0023-9637-04)  / 4 d in 1 PATCH",
      "package_ndc": "0023-9637-04",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20160101"
    },
    {
      "sample": false,
      "description": "32 PATCH in 1 CARTON (0023-9637-08)  / 4 d in 1 PATCH",
      "package_ndc": "0023-9637-08",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20191001"
    }
  ],
  "productId": "0023-9637_cc404430-2345-4294-8efc-e1e996cc17b2",
  "useDomain": "unknown",
  "dosageForm": "PATCH",
  "productNdc": "0023-9637",
  "deaSchedule": null,
  "genericName": "Oxybutynin",
  "productType": "HUMAN OTC DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "OXYBUTYNIN",
      "strength": "3.9 mg/d"
    }
  ],
  "applicationNumber": "NDA202211",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20160101",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "non-prescription",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175700",
      "N0000000125"
    ],
    "unii": [
      "K9P6MC7092"
    ],
    "rxcui": [
      "403799",
      "404448"
    ],
    "spl_set_id": [
      "8cdc5b4d-ff8d-4010-97d7-313422a0b868"
    ],
    "pharm_class_epc": [
      "Cholinergic Muscarinic Antagonist [EPC]"
    ],
    "pharm_class_moa": [
      "Cholinergic Muscarinic Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "Allergan, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0023-9637_cc404430-2345-4294-8efc-e1e996cc17b2"